← Eichor
Study identifier: NCT06764615 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)

Condition: Crohn's Disease · Ulcerative Colitis  ·  Sponsor: Takeda

PhasePhase 2
Planned participants192
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

Crohn's Disease and Ulcerative Colitis are two types of inflammatory bowel disease (IBD), which is a serious, long-term condition in the gut (intestine) that can cause pain and swelling (inflammation) in the bowel. TAK-279 is a medicine which helps to block inflammation. This study is an extension of the parent studies, TAK-279-CD-2001 (NCT06233461), TAK-279-UC-2001 (NCT06254950) and TAK-279-CD-2003 (NCT07403968). This means that participants who responded to treatment with TAK-279 in either of the parent studies may be able to continue to benefit from the treatment in this study. The main aim of this study is to find out how safe TAK-279 is for long term use and to check if it reduces bowel inflammation and symptoms when used for a longer period of time in adults with moderately to severely active UC or CD. The participants will be treated with TAK-279 for up to 3 years (156 weeks). During the study, participants will visit their study clinic around 15 times.

This description comes directly from the study's public registry record.

Talk to the study team

Takeda Contact  ·  +1-877-825-3327  ·  medinfoUS@takeda.com

Always discuss trial participation with your own doctor first.

Locations (16)

Woodholme Gastroenterology AssociatesGlen Burnie, Maryland, United StatesRecruiting
Tyler Research Institute, LLCTyler, Texas, United StatesRecruiting
Chongqing General HospitalChongqing, Chongqing Municipality, ChinaRecruiting
The First Affiliated Hospital of Sun Yat-sen UniversityGuangdong, Guangdong, ChinaRecruiting
The Sixth Affiliated Hospital of Sun Yat-sen UniversityGuangzhou, Guangdong, ChinaRecruiting
Renji Hospital Shanghai Jiaotong University School of MedicineShanghai, Shanghai Municipality, ChinaRecruiting
Hepato-Gastroenterologie HK s.r.o.Hradec Králové, CzechiaRecruiting
Pannonia Maganorvosi CentrumBudapest, HungaryRecruiting
St. Antonius ZiekenhuisTilburg, North Brabant, NetherlandsRecruiting
Gastromed Kopon Zmudzinski i Wspolnicy Sp.j.Specjalistyczne Centrum Gastrologii i Endoskopii SpecjTorun, Kuyavian-Pomeranian Voivodeship, PolandRecruiting
Centrum Medyczne MedykSp. z o.o. Sp. K.Lublin, PolandRecruiting
Twoja Przychodnia - Szczecinskie Centrum MedyczneSzczecin, PolandRecruiting

+ 4 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06764615